FDA panel recommends approval of Staar Surgical's novel eye implant

The FDA's ophthalmic devices advisory panel votes that Staar Surgical's breakthrough implantable lens is safe and effective and that its benefits outweigh its risks. An FDA panel voted today to recommend approval for Staar Surgical's (NSDQ:STAA) novel Visian Toric implantable collamer lens for treatment of myopic astigmatism in adults aged 21-45. Food & Drug Administration (FDA), STAAR Surgical Co.News Well, Regulatory/Clearance, Food & Drug Administration (FDA), Optical/Ophthalmic, Pre-Market Approval (PMA)read more
Source: Mass Device - Category: Medical Equipment Authors: Source Type: news